Azenosertib Recruiting Phase 2 Trials for Uterine Serous Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04814108A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma